03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Amlor 5mg* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mectapharm |
Distributor | Mectapharm |
Laboratory | Pfizer |
Responsible Party | Pfizer Corporation |
Origin | Belgium |
Manufacturer | Pfizer Corporation |
Origin | Belgium |
ATC | C08CA01 |
Revision Date | 08/08/2001 |
Amlor 5mg* :
Amlor 5mg* :
Amlor 5mg* :
Amlor 5mg* :
Amlor 5mg* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Amlor 5mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Allergic reaction | Very rare |
Alopecia | Uncommon |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Ankle oedema | Common |
Anxiety | Uncommon |
Arthralgia (Pain joint) (Joint ache) | Uncommon |
Asthenia | Common |
Atrial fibrillation | Uncommon |
Back pain | Uncommon |
Bowel motility disorder | Common |
Bradycardia | Uncommon |
Cephalea | Common |
Chest pain | Uncommon |
Confusion | Rare |
Constipation | Common |
Cough | Uncommon |
Depression | Uncommon |
Dermatitis exfoliative | Very rare |
Diarrhoea (Diarrhea) | Common |
Diplopia | Common |
Dizziness | Common |
Dry mouth (Xerostomia) | Uncommon |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Uncommon |
Dyspepsia | Common |
Dyspnoea (dyspnea) | Common |
Erythema multiforme | Very rare |
Exanthema | Uncommon |
Fatigue | Common |
Flushing | Common |
Gastritis | Very rare |
Gingival hyperplasia | Very rare |
Gynecomastia (Gynaecomastia) | Uncommon |
Hepatic enzyme increased | Very rare |
Hepatitis | Very rare |
Hyperglycaemia | Very rare |
Hyperhidrosis | Uncommon |
Hypertonia | Very rare |
Hypoesthesia | Uncommon |
Hypotension | Uncommon |
Impotence | Uncommon |
Insomnia | Uncommon |
Jaundice | Very rare |
Leucopenia (Leukopenia) | Very rare |
Malaise | Uncommon |
Micturition disorder | Uncommon |
Muscle cramps | Common |
Myalgia | Uncommon |
Myocardial infarction | Very rare |
Nausea | Common |
Neuropathy peripheral | Very rare |
Nocturia | Uncommon |
Oedema | Very Common |
Pain | Uncommon |
Palpitations | Common |
Pancreatitis | Very rare |
Paraesthesia (paresthesia) | Uncommon |
Photosensitivity | Very rare |
Pollakiuria (Urinary frequency) | Uncommon |
Pruritus | Uncommon |
Purpura | Uncommon |
Rhinitis | Uncommon |
Skin discolouration (Dyschromia) | Uncommon |
Skin Eruption | Uncommon |
Somnolence | Common |
Stevens-Johnson syndrome | Very rare |
Syncope | Uncommon |
Thrombocytopenia (Thrombopenia) | Very rare |
Tinnitus | Uncommon |
Tremor | Uncommon |
Urticaria | Uncommon |
Vasculitides | Very rare |
Ventricular tachycardia | Uncommon |
Visual disturbance | Common |
Vomiting | Uncommon |
Weight decreased (Weight loss) | Uncommon |
Weight increased (weight gain) | Uncommon |
Amlor 5mg* :
Amlor 5mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Amlor 5mg* MoH 2527 :
Form | Capsule, hard |
Packaging | Blisters |
Package Size | Box of 28 |
Strength | 5mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 27602 |
Submission date | 01/01/2009 |
Registration Year | 2008 |
Archived Date | 2014 |
Price Comparison
● Country: | KSA | |
● Package Size: | 30 | |
● Public Price: | 63.85 SAR | ( 1,509,414.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 2,1283 SAR | ( 47,280.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 30 | |
● Public Price: | 6.89 OMR | ( 1,589,757.26 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,2297 OMR | ( 0.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 30 | |
● Public Price: | 16.9 CHF | ( 1,747,798.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,5633 CHF | ( 0.00 LBP ) |
● Exfactory Price: | 7.59 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 30 | |
● Public Price: | 6.67 BHD | ( 1,585,685.78 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,2223 BHD | ( 0.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 | |
● Type: | Medicine Authorised |
● Country: | France | |
● Package Size: | 30 | |
● Public Price: | 5.38 EUR | ( 521,192.88 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,1793 EUR | ( 0.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Withdrawn |
● Country: | Belgium | |
● Package Size: | 28 | |
● Public Price: | 9.99 EUR | ( 967,791.24 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,3568 EUR | ( 0.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 27/11/2020 | |
● Type: | Medicine Authorised |
● Country: | Ireland | |
● Package Size: | 28 | |
● Public Price: | 1.68 EUR | ( 162,751.68 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,06 EUR | ( 0.00 LBP ) |
● Exfactory Price: | 2 EUR | |
● Pricing Date: | 01/08/2019 | |
● Type: | Medicine Non Marketed |
● Country: | Cyprus | |
● Package Size: | 14 | |
● Public Price: | 8.33 EUR | ( 806,977.08 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 0,595 EUR | ( 0.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 | |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File